Astera Labs (NASDAQ:ALAB) Stock Price Up 9.1% – Time to Buy?

Astera Labs, Inc. (NASDAQ:ALAB) shot up 9.1% during mid-day trading on Thursday . The company traded as high as $293.92 and last traded at $293.56. 4,133,301 shares changed hands during trading, a decline of 21% from the average session volume of 5,247,150 shares. The stock had previously closed at $269.18.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on ALAB. Barclays upped their price target on shares of Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research note on Monday, July 20th. Susquehanna lifted their price objective on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a report on Friday, July 31st. Zacks Research upgraded shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. TD Cowen reduced their price target on Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a research report on Wednesday, August 5th. Finally, Morgan Stanley increased their price objective on shares of Astera Labs to $335.00 and gave the stock an “overweight” rating in a research note on Monday, August 3rd. One investment analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $348.33.

Astera Labs Price Performance

The stock has a market capitalization of $50.93 billion, a PE ratio of 145.33 and a beta of 3.77. The firm has a fifty day moving average price of $308.00 and a two-hundred day moving average price of $263.90.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. The business’s revenue was up 104.5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, research analysts expect that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 8,994 shares of the company’s stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $311.83, for a total value of $2,804,599.02. Following the completion of the sale, the director directly owned 3,970 shares in the company, valued at approximately $1,237,965.10. This represents a 69.38% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total value of $51,263,790.00. Following the completion of the sale, the director owned 253,863 shares of the company’s stock, valued at $71,114,642.19. This represents a 41.89% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 592,244 shares of company stock valued at $209,729,973 over the last 90 days. 10.40% of the stock is owned by insiders.

Institutional Trading of Astera Labs

Hedge funds have recently added to or reduced their stakes in the business. Greenleaf Trust raised its holdings in Astera Labs by 1.8% in the 2nd quarter. Greenleaf Trust now owns 2,000 shares of the company’s stock worth $966,000 after purchasing an additional 36 shares during the period. Parkside Financial Bank & Trust grew its holdings in Astera Labs by 74.5% in the second quarter. Parkside Financial Bank & Trust now owns 96 shares of the company’s stock valued at $46,000 after purchasing an additional 41 shares during the period. Glenmede Trust Co. NA grew its holdings in Astera Labs by 2.7% in the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock valued at $209,000 after purchasing an additional 51 shares during the period. Keating Financial Advisory Services Inc. purchased a new stake in shares of Astera Labs in the second quarter valued at approximately $25,000. Finally, Integrated Wealth Concepts LLC increased its position in shares of Astera Labs by 0.7% in the second quarter. Integrated Wealth Concepts LLC now owns 7,006 shares of the company’s stock valued at $3,384,000 after buying an additional 52 shares in the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.

The company’s portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.